Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States. Its lead product candidate is GP2, a HER2/neu transmembrane peptide, which is in Phase III clinical trial to prevent breast cancer recurrences in patients. The company also develops FLAMINGO-01, which is in Phase IIb and 3 Phase I clinical trial designed to evaluate the safety and efficacy of GLSI-100 in HER2 positive breast cancer patients. Greenwich LifeSciences, Inc. was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. The company was incorporated in 2006 and is headquartered in Stafford, Texas.
Frequently asked questions
What sector does Greenwich LifeSciences, Inc (GLSI) operate in?
Greenwich LifeSciences, Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Greenwich LifeSciences, Inc (GLSI) current stock price?
As of the latest data, Greenwich LifeSciences, Inc stock price is $16.91, with a previous close of $17.13. Greenwich LifeSciences, Inc lost -$0.22 in the last trading session, representing a -1.26% loss.
What is Greenwich LifeSciences, Inc (GLSI) current market capitalization?
Greenwich LifeSciences, Inc market cap is approximately 248.21 million.
What is Greenwich LifeSciences, Inc (GLSI) Earnings Per Share (EPS)?
The trailing EPS is -$1.59, and the forward EPS is -$1.17.
What is Greenwich LifeSciences, Inc (GLSI) EBITDA?
Greenwich LifeSciences, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -3.95 million.
Does Greenwich LifeSciences, Inc (GLSI) pay dividends?
No. Greenwich LifeSciences, Inc does not pay a dividend.
When is Greenwich LifeSciences, Inc (GLSI) next earnings report?
Greenwich LifeSciences, Inc is expected to release its next earnings report on September 30, 2026.
What is Greenwich LifeSciences, Inc (GLSI) beta (volatility) score?
Greenwich LifeSciences, Inc has a beta of 1.462, suggesting it is more volatile than the market.
